ATF6 and chronic kidney disease: Masuda et al. demonstrate that vascular smooth muscle calcification arising during chronic kidney disease is mediated by increased reactive oxygen species and TNF-α–inducing PERK signaling but no difference in ATF6 or IRE1 activation (21).